Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Gavin Malenfant
View:
Post by Mole101 on Sep 28, 2021 5:15pm

Gavin Malenfant

2021-09-2813:39
 
2021-09-22
$PMN Malenfant, Gavin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$665,000 
+3,500,000vol 
$0.19 each
3,500,000  
2021-09-2813:38
 
2021-09-22
$PMN Malenfant, Gavin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
 
Comment by Speyeder999 on Sep 28, 2021 7:33pm
 Nice find Mole. Our new CEO? https://biography.omicsonline.org/united-states-of-america/akebia-therapeutics/gavin-malenfant-1024373    
Comment by Mole101 on Sep 28, 2021 10:18pm
Now that PMN has $$$ I believe they brought him back ... Gavin Malenfant Work Experience and Education Work Experience   Senior VP, R&D Operations ProMIS™ Neurosciences 2018-2019 Corporate Operations & Program Management ...more  
Comment by JackRedwood on Sep 29, 2021 6:35pm
So this guy bought 655,000 USD worth of Shares and is in line to become CEO ? 
Comment by retiredcop on Sep 29, 2021 9:10pm
I think the shares were granted to him when he was hired to do what ever he is going to do    He can buy shares later 
Comment by JackRedwood on Sep 29, 2021 10:04pm
Thanks for the clear up RC
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities